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Objective. There is increasing evidence of adverse outcomes associated with blood transfusions for adult traumatic brain injury
patients. However, current evidence suggests that pediatric traumatic brain injury patients may respond to blood transfusions
differently on a vascular level. This study examined the influence of blood transfusions and anemia on the outcome of pediatric
traumatic brain injury patients. Design. A retrospective cohort analysis of severe pediatric traumatic brain injury (TBI) patients
was undertaken to investigate the association between blood transfusions and anemia on patient outcomes. Measurements and
Main Results. One hundred and twenty patients with severe traumatic brain injury were identified and included in the analysis.
Themedian Glasgow Coma Scale (GCS) was 6 and the mean hemoglobin (Hgb) on admission was 115.8 g/L. Forty-three percent of
patients (43%) received at least one blood transfusion and the mean hemoglobin before transfusion was 80.1 g/L. Multivariable
regression analysis revealed that anemia and the administration of packed red blood cells were not associated with adverse
outcomes. Factors that were significantly associated with mortality were presence of abusive head trauma, increasing PRISM score,
and low GCS after admission. Conclusion. In this single centre retrospective cohort study, there was no association found between
anemia, blood transfusions, and hospital mortality in a pediatric traumatic brain injury patient population.
1. Background
Traumatic brain injury (TBI) is a leading cause of pedi-
atric morbidity and mortality, accounting for approximately
60,000 hospitalizations and 7,400 deaths per year [1]. Sub-
stantial work has been done on anemia and transfusions in
both adult and pediatric critically ill patients [2, 3]. Several
adult studies have shown an association between anemia,
blood transfusions, and poorer outcomes in patients with
severe TBI [4, 5].
While the current adult literature is gaining increasing
evidence that there may be an adverse effect of transfusion
on TBI patients, these results may not be generalizable
to pediatric patients. Significant differences exist between
pediatric and adult cerebral blood flow (CBF) in both normal
and traumatic-injured states [6]. CBF and cerebral metabolic
rates are higher in children [6]. In addition, pediatric patients
have increased CO
2
vasoreactivity and have a CBF autoreg-
ulation system that is easier to disrupt [6]. The type of
blood being used in pediatric patients may also affect the
outcome. Lacroix et al. determined that pediatric patients
often received leukocyte reduced blood compared to adults
who did not [3].
Further, pediatric TBI patients may respond to blood
transfusions differently compared to adults. Figaji et al.
reported that 79% of their pediatric TBI patients demon-
strated an improvement in brain oxygenation after a trans-
fusion [7]. This is in contrast to the 57% of adult TBI patients
that had an improvement in brain oxygenation after a blood
transfusion [8].
The Transfusion Requirements in Pediatric Intensive
Care Unit (TRIPICU) trial demonstrated that adopting a
restrictive blood transfusion threshold of a hemoglobin
(Hgb) level of 70 g/L in stable critically ill children results
in no difference in mortality, but they did not look at
TBI patients specifically [3]. Comprehensive evidence-based
guidelines have been created to optimize the management of
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pediatric TBI patients, but there is no consensus on when
to transfuse pediatric TBI patients [9]. We performed a
retrospective cohort study of pediatric severe TBI patients
admitted to the pediatric intensive care unit (PICU) to
determine if there is any association between anemia and
blood transfusions with mortality in these patients.
2. Materials and Methods
Approval from the Conjoint Health Research Ethics Board
at the University of Calgary was obtained (Study ID REB13-
0095) and informed consent was waived. Patients with a
diagnosis of TBI admitted to the Alberta Children’s Hospital
(ACH) PICU between January 2001 and December 2012 had
their charts analyzed by the study investigators. Inclusion
criteria were <18 years of age, admission to ACH PICU
with diagnosis of TBI or skull fracture, and initial Glasgow
Coma Scale (GCS) of ≤8. Exclusion criteria included patient
obeying commands within 12 hours of admission, patient
death within 12 hours of admission (with injuries likely so
severe that blood transfusions would be unlikely to alter their
course), nontraumatic etiology to explain decreased level
of consciousness (e.g., alcohol or drugs), and concomitant
traumatic quadriparesis (unable to assessGCS).These criteria
were modelled after a similar study in adult TBI patients [5].
No sampling was done and all patients who met eligibility
criteria were included for analysis.
Data was collected on standardized case report forms.
Aside from standard demographic information, additional
data collected included patient initial hemoglobin and mean
hemoglobin for up to the next 7 days after admission; type
and severity of the injury characterized by initial vital signs
and GCS scores; mechanism of injury; surgical procedures
performed; and the presence of signs indicative of raised
intracranial pressure (ICP) on CT scans, as reported by a
radiologist. At our institution, all patients with severe TBI
receive radiologic studies as part of their workup, but not
all patients receive invasive ICP monitoring. Presence of
intracranial hemorrhage and other injurieswas also collected.
Recording of patient management data included transfusions
in the first 14 days, use of mannitol or hypertonic saline, ther-
apeutic hypothermia, and administration of neuromuscular
blockade. Length of hospital and ICU stay along with all-
cause mortality within 30 days was used as our primary end-
points.
A database containing all previously admitted pediatric
patients diagnosed from the desired time period was created.
All patients with diagnosis codes of brain injury, traumatic
cerebral edema, skull fractures, wounds to head, face, or scalp,
and intracranial bleeding admitted to the PICU formore than
24 hours were included in the initial screening.
Presented patient demographic and clinical data are
expressed as the mean ± SD or median with interquartile
range (IQR) dependent on data normality as assessed using
the Shapiro-Wilk test (𝑝 < 0.05). Given the potential prac-
tice change of the publication of the landmark transfusion
threshold study in critically ill children by Lacroix et al.,
we stratified the patients according to whether they were






(i) 9 patients died within 24 hours
(ii) 143 patients had GCS score >12
within first 12 hours
(iii) 194 patients had nontraumatic
CNS injury
Figure 1: Total number of patients screened and included into the
study. TBI: traumatic brain injury. GCS: Glasgow Coma Scale. CNS:
central nervous system.
(𝑝 < 0.05) in continuous demographic and clinical variables
between those transfused and not transfused were assessed
using the independent samples 𝑡-test or Mann Whitney 𝑈-
test upon failure of data normality. Significant differences
(𝑝 < 0.05) in categorical variables were assessed using the chi-
square test for association or Fisher’s exact test.
An exploratory model to predict the probability of mor-
tality was developed using logistic regression. Seven inde-
pendent variables (age, presence of suspected nonaccidental
trauma (NAT), PRISM III score, RBC transnfusion, admis-
sion GCS score, admission Hgb, and 7-day mean Hgb) were
initially considered as possible covariates. Prior to model
construction, a correlation of 𝜌 = 0.65 was found between
admission Hgb and 7-day mean Hgb using Spearman’s rank
coefficient. Univariate logistic regression was used to assess
the strength of admission and 7-day mean Hgb in predicting
the probability of mortality. Nagelkerke 𝑅2 values were 0.1
and 0.02 for admission and 7-day mean Hgb, respectively,
supporting the consideration of admission Hgb as a covariate
in our predictive logistic regression model. Additionally, an
interaction term of RBC infusion ∗ admission Hgb was also
considered as a possible covariate.
The criteria of variable selection for model inclusion fol-
lowed that of Hosmer Jr. et al. [10]. Briefly, variable selection
began with univariate analysis of each independent variable
via chi-square analysis for categorical variables (presence of
NAT and RBC infusion) and univariate logistic regression for
continuous variables. Candidate variables were considered if
𝑝 < 0.2 and as such, all seven covariates were included in
an initial predictive model. Results from the initial predictive
model of mortality guided the generation of a refined model
using only covariates that presented with 𝑝 < 0.05 [10]. The
refined, reduced covariate model was compared to the full
covariate model using the likelihood ratio chi-square test. All
statistical tests were completed using IBM SPSS 20.0 statistics
software (IBM, Armonk, NY, USA).
3. Results
A total of 466 patients with TBI were screened for possible
study inclusion (Figure 1). One hundred and twenty met
the inclusion criteria. Fifty-three patients (44%) received
blood transfusions. Of these patients, the average number of
transfusions was 1.67.
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Table 1: Demographic information. GCS: Glasgow Coma Scale. Hgb: hemoglobin. PRISM III: pediatric risk of mortality III score. SD:
standard deviation. Values represented as “x (y)” are the median (interquartile range). Values with “x ± y” are mean ± SD.
Clinical variable Patients transfused (𝑛 = 53) Patients not transfused (𝑛 = 67) 𝑝 value
Mean age (years) 3.5 (3.5) 11.3 (10.6) <0.005
Male gender (%) 32 (60) 47 (70) 0.262
Year of admission (%)
2001–2006 28 (52) 34 (51) 0.821
2007–2012 25 (48) 33 (49) 0.821
Mechanism of injury
Motor vehicle accident 23 (43) 26 (39) 0.611
Fall 3 (6) 9 (13) 0.159
Assault 10 (19) 10 (15) 0.565
Accidental 17 (32) 22 (33) 0.930
Suspected nonaccidental trauma (%) 12 (23) 14 (21) 0.818
Mortality (%) 13 (25) 7 (10) 0.040
PRISM III score 10.0 (9) 5.0 (2) <0.005
Mean ICU length of stay (days) 6.0 (6) 3.0 (2) <0.005
Mean hospital length of stay (days) 15.0 (22) 9.0 (13) 0.049
Patients with ICP monitor (%) 26 (49) 8 (12) <0.005
Mean daily ICP (mmHg)
Day 1 12.0 (8) 17.0 (14) 0.624
Day 2 14.0 (8) 16.0 (12) 0.815
Day 3 16.0 (8) 18.0 (8) 0.477
Day 4 14.0 (8) 15.0 (13) 0.673
Day 5 14.0 (10) 18.0 (53) 0.622
Day 6 18.0 ± 10.8
Day 7 16.5 ± 4.4
Admission Glasgow Coma Scale (GCS) 3.0 (4) 6.0 (4) 0.009
Surgical procedures performed (%)
0 27 (51) 55 (82) <0.005
1 10 (19) 7 (10) 0.189
2 16 (30) 5 (7) 0.001
Presence of raised ICP on imaging (%) 32 (60) 20 (30) 0.001
Presence of intracranial hemorrhage (%) 39 (74) 39 (58) 0.079
Intracranial hypertension medical management (%)
Mannitol admin 21 (40) 10 (15) 0.002
3% NaCl admin 6 (11) 4 (6) 0.292
Hypothermia 8 (15) 9 (13) 0.795
Use of neuromuscular blockade (%) 21 (40) 19 (28) 0.194
Admission Hgb (g/L) 101.6 ± 24.6 126.7 ± 13.9 <0.005
Nadir Hgb in first 7 days (g/L) 83.0 (20) 105.0 (18) <0.005
Mean Hgb over first 7 days (g/L) 106.8 (12) 115.8 (14.5) <0.005
Mean number of transfusions 1.67 ± 1.78
Patient demographic and clinical data is summarized
in Table 1. Statistically significant differences (𝑝 < 0.05)
between patients transfused and not transfused were noted
in age, mortality, PRISM III score, ICU length of stay,
hospital length of stay, patients with ICP monitor, initial
GCS, surgical procedures performed, presence of raised ICP
on imaging, mannitol administration, admission Hgb, nadir
Hgb in first 7 days, and mean Hgb over first 7 days. Of
the patients who received blood transfusions, 26 patients
received invasive ICP monitoring, while 8 patients in the
nontransfused group did. One patient was excluded from
the length-of-stay calculations as they were transferred to
another facility before they were discharged, but their data
was used in the main analysis.
The reduced covariate logistic regression model (Table 2)
to predict the probability of mortality was statistically sig-
nificant (𝜒2 = 47.4; 𝑝 < 0.05) and included presence of
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Table 2: Statistical outputs of initial exploratory logistic regression model with seven covariates (a) and final reduced covariate (b) logistic
regression model to predict the probability of mortality.
(a)




NAT suspected 2.434 0.989 0.014 11.40 1.64–79.25
PRISM III score 0.222 0.072 <0.005 1.25 1.08–1.44
Age 0.039 0.094 0.679 1.04 0.87–1.25
Admission GCS −0.303 0.226 0.179 0.74 0.47–1.15
Initial Hgb −0.057 0.042 0.174 0.95 0.87–1.03
RBC transfusion −5.688 5.366 0.289 0.00 0.00–125.17
Initial Hgb ∗ RBC
transfusion 0.046 0.045 0.302 1.05 0.96–1.14
Constant 3.094 5.468 0.572 22.06
𝑅
2 = 0.586; 𝜒2 = 51.1.
(b)
Variables 𝛽 Standarderror 𝑝 value Odds ratio
95% CI odds ratio
(lower-upper)
NAT suspected 2.198 0.730 <0.005 9.011 2.155–37.684
PRISM III score 0.276 0.060 <0.005 1.317 1.171–1.482
Constant −5.294 0.937 <0.005 0.005
𝑅
2 = 0.552; 𝜒2 = 47.4.
NAT: nonaccidental trauma; GCS: Glasgow Coma Scale; Hgb: hemoglobin; RBC: red blood cell.
suspected NAT and PRISM III score as significant (𝑝 < 0.05)
covariates:
Log odds (mortality)
= −5.294 + (2.198 ∗ presence of suspected NAT)
+ (0.276 ∗ PRISM III score) .
(1)
Odds ratios were 9.01 (95% CI: 2.16–37.68) and 1.32 (95%
CI: 1.17–1.48) for presence of suspected NAT and PRISM
III score, respectively. The model explained 55.2% of the
variance in mortality (Nagelkerke 𝑅2) and correctly classified
89.1% of patients. Sensitivity and specificity were 50% and
97%, respectively.The likelihood ratio chi-square test was not
significant (𝜒2 = 3.70; 𝑝 = 0.594).
4. Discussion
In this retrospective cohort study of 120 pediatric patients
with severe TBI admitted to our PICU, it was found that
hemoglobin at time of admission, administration of blood
transfusions, and 7-day average hemoglobin after admission
were not associated with adverse outcomes. Significant vari-
ables that were associated with increased mortality were the
presence of suspected NAT and increasing PRISM score.
It should be noted that therewas a significant difference in
the patients that were transfused and those that were not.The
patients receiving blood transfusions tended to be younger
and less well. Despite these differences, there was no clinical
outcome difference associated with hemoglobin levels and
transfusions.
The goals of TBI management are to prevent secondary
insults to the brain after the initial injury, including injury
caused by hypoxia and hypotension [9, 11]. Hemoglobin is
the major carrier of oxygen in the systemic circulation and
there are many conflicting studies examining the relationship
between anemia and TBI outcome. Sekhon and colleagues
showed that a mean 7-day hemoglobin of less than 90 g/L
resulted in increased hospital mortality in severe adult TBI
patients [5].
In a large retrospective study of adult TBI patients, Salim
and colleagues demonstrated that anemia and correction
of it by blood transfusion are associated with increased
mortality [4]. Similarly, Warner and colleagues found that
adult patients receiving transfusions for moderate anemia
after suffering TBI had long-term reduced function at 6
months [12]. In our study, we were not able to record good
neurologic outcome data since they were often not doc-
umented. Currently, no association between administering
blood transfusions and positive outcomes can be made in
adult TBI patients and our study supports this assertion in
pediatric TBI patients. However, one cannot separate the
effects of transfusion with the effects of anemia on outcome
in TBI. This is a limitation of the retrospective design of our
study, as well as the published adult studies.
Similar to Sekhon and colleagues, we chose to studymea-
sured exposure to hemoglobin levels by looking at the initial
and average hemoglobin for up to 7 days after admission. A
variety of methods have been used to observe hemoglobin
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levels, but 7 days is thought to capture the occurrence of peak
ICP [13]. Like their study, we also captured transfusions as a
time-insensitive dichotomous variable that cannot take into
context the circumstances surrounding the administration
of blood. We recognize that our results may be affected by
a survival bias since we did not collect the exact time of
death for those patients who died. It is well recognized that,
in pediatric critical care, decisions to withdraw life support
and the subsequent timing of this withdrawal are heavily
affected by the patient’s social and cultural backgrounds,
so the time of death may not always be based on purely
medical circumstances. This makes the link between time
of death and severity of illness very difficult in our context
[14, 15].
Other limitations of this study include the retrospec-
tive nature and the long period of time during which
patient information was gathered. During this period of data
collection, management strategies may have changed over
time, which may have also affected our results. Having said
that, our multivariate logistic regression analysis did not
show an association between other management strategies
and outcomes. All patients reviewed were admitted to a
single centre suggesting that our results may not be entirely
generalizable to other hospitals. However, the fact that our
study found associations between NAT, GCS, and PRISM
scores suggests that our study population is similar to other
pediatric TBI studies that identified these as factors as well
[16–18].
In conclusion, initial admission Hgb and mean Hgb
values averaged over seven days after admission to PICU
were not found to be strong predictors of mortality in
children with severe TBI. No difference in outcome can be
demonstrated when patients are transfused. Based on our
study, we cannot advocate for deviation from the widely
accepted transfusion threshold of 7 g per deciliter in critically
ill pediatric patients presenting with TBI [3]. Prospective
evaluation of the association among anemia, transfusion, and
outcome should be undertaken to further define any possible
relationship.
Disclosure
The study institution where this research was carried out is
Section of Critical Care, Department of Pediatrics, Faculty of
Medicine, University of Calgary, Alberta Children’s Hospital,
2888 Shaganappi Trail NW, Calgary, AB, Canada T3B 6A8.
Competing Interests
The authors declare that they have no competing interests.
Acknowledgments
The authors would like to thank Dr. Jong Rho and the
Section of Neurology in the Department of Pediatrics in the
Cumming School ofMedicine at theUniversity of Calgary for
providing departmental funds to support this study.
References
[1] R. M. Stanley, B. K. Bonsu, W. Zhao, P. F. Ehrlich, A. J. Rogers,
and H. Xiang, “US estimates of hospitalized children with
severe traumatic brain injury: implications for clinical trials,”
Pediatrics, vol. 129, no. 1, pp. e24–e30, 2012.
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